Zhicheng Tian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhicheng Tian has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Peng Luo
Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China
4 shared publications - Xiaofan Jiang
Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China
3 shared publications Zixuan Cao
Department of Neurosurgery, Xijing Hospital Fourth Military Medical University Xi'an China
3 shared publications- Haofuzi Zhang
Department of Plastic, Aesthetic and Maxillofacial Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, P.R. China
2 shared publications Tianjing Li
Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China
2 shared publications- Xin Li
Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi’an, China
2 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (11)
From Mechanical Perturbation to Pathological Locking: Temporal–Mechanical Evolution of the Postsynaptic Density After Traumatic Brain Injury
Background: Traumatic brain injury (TBI) induces persistent cognitive deficits, yet conventional biochemical and structural models often fail to explain synaptic signal collapse in the absence of overt tissue rupture. Results: Here, we present a hypothesis‐generating mechanobiological framework that positions postsynaptic density (PSD)—a multivalent protein condensate governed by liquid–liquid phase separation (LLPS)—as a primary locus of synaptic mechanovulnerability. We argue that TBI‐induced synaptic pathology is not merely a quantitative loss of molecular components, but a progressive, staged material state transition of the PSD network. This pathological evolution initiates with hyperacute mechanical deconstruction, leading to physical scaffold decoupling and nanoscale receptor misalignment. It then advances through an acute mechano‐metabolic crisis characterized by enzymatic scaffold cleavage and impaired re‐condensation, ultimately culminating in a chronically locked, low‐dynamic “solidified” state. Furthermore, post‐injury extracellular matrix stiffening and the mechanical exposure of cryptic epitopes trigger aberrant microglial pruning via mechanosensors such as Piezo1, permanently dismantling neural circuits. Because the supporting evidence is heterogeneous, we explicitly grade each element of this model as established directly in TBI, supported in non‐TBI synaptic systems, extrapolated from reconstituted condensates, or hypothetical. Conclusions: By bridging macroscopic biomechanics with nanoscale molecular pathology, this review highlights a critical conceptual gap and proposes “mechano‐therapeutics” as a hypothesis‐generating concept rather than an established treatment avenue. We suggest that strategies targeting the physical properties of the synapse, such as stabilizing scaffold oligomerization, modulating mechanotransduction pathways, and restoring physiological tissue stiffness, are candidate directions whose feasibility, delivery, cell‐type specificity, timing, and safety must first be established in preclinical models before any clinical translation to rescue synaptic homeostasis and cognitive function after TBI.
- 6 November 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (11)
Open AccessFrom Mechanical Perturbation to Pathological Locking: Temporal–Mechanical Evolution of the Postsynaptic Density After Traumatic Brain Injury
Background: Traumatic brain injury (TBI) induces persistent cognitive deficits, yet conventional biochemical and structural models often fail to explain synaptic signal collapse in the absence of overt tissue rupture. Results: Here, we present a hypothesis‐generating mechanobiological framework that positions postsynaptic density (PSD)—a multivalent protein condensate governed by liquid–liquid phase separation (LLPS)—as a primary locus of synaptic mechanovulnerability. We argue that TBI‐induced synaptic pathology is not merely a quantitative loss of molecular components, but a progressive, staged material state transition of the PSD network. This pathological evolution initiates with hyperacute mechanical deconstruction, leading to physical scaffold decoupling and nanoscale receptor misalignment. It then advances through an acute mechano‐metabolic crisis characterized by enzymatic scaffold cleavage and impaired re‐condensation, ultimately culminating in a chronically locked, low‐dynamic “solidified” state. Furthermore, post‐injury extracellular matrix stiffening and the mechanical exposure of cryptic epitopes trigger aberrant microglial pruning via mechanosensors such as Piezo1, permanently dismantling neural circuits. Because the supporting evidence is heterogeneous, we explicitly grade each element of this model as established directly in TBI, supported in non‐TBI synaptic systems, extrapolated from reconstituted condensates, or hypothetical. Conclusions: By bridging macroscopic biomechanics with nanoscale molecular pathology, this review highlights a critical conceptual gap and proposes “mechano‐therapeutics” as a hypothesis‐generating concept rather than an established treatment avenue. We suggest that strategies targeting the physical properties of the synapse, such as stabilizing scaffold oligomerization, modulating mechanotransduction pathways, and restoring physiological tissue stiffness, are candidate directions whose feasibility, delivery, cell‐type specificity, timing, and safety must first be established in preclinical models before any clinical translation to rescue synaptic homeostasis and cognitive function after TBI.
- Open Access
- 29 August 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (9) , 921
Peripheral Nerve Injury Induces an Interferon-Responsive State Centered on Satellite Glial Cells in the DRG That Sustains Neuropathic Pain Through STAT1 and CXCL10 Signaling
Background: Peripheral nerve injury drives persistent remodeling of the dorsal root ganglion (DRG) microenvironment, but the cellular states and intercellular signaling mechanisms that sustain neuropathic pain remain poorly understood. Methods: Here, we integrated single-cell transcriptomics with histological, behavioral, and electrophysiological approaches to identify an interferon-responsive state in satellite glial cells (SGCs) of the DRG following spared nerve injury (SNI). Results: This state was distinguished by STAT1-associated interferon-responsive genes’ activation and enhanced chemokine signaling, particularly involving CXCL10 and its receptor CXCR3. These molecular alterations were accompanied by remodeling of intercellular communication among SGCs, sensory neurons, and immune cells. Pharmacological inhibition of STAT1 or blockade of CXCR3 not only reduced sensory-neuron hyperexcitability but also attenuated pain hypersensitivity and improved deficits in hindlimb weight bearing and gait after SNI. Conclusions: Collectively, our findings indicate that interferon-responsive SGCs (IFN SGCs) contribute to the maintenance of neuropathic pain by regulating STAT1-dependent chemokine signaling in the DRG. Targeting this signaling pathway may provide a therapeutic strategy for persistent neuropathic pain.
- 29 August 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (9) , 921
Open AccessPeripheral Nerve Injury Induces an Interferon-Responsive State Centered on Satellite Glial Cells in the DRG That Sustains Neuropathic Pain Through STAT1 and CXCL10 Signaling
Background: Peripheral nerve injury drives persistent remodeling of the dorsal root ganglion (DRG) microenvironment, but the cellular states and intercellular signaling mechanisms that sustain neuropathic pain remain poorly understood. Methods: Here, we integrated single-cell transcriptomics with histological, behavioral, and electrophysiological approaches to identify an interferon-responsive state in satellite glial cells (SGCs) of the DRG following spared nerve injury (SNI). Results: This state was distinguished by STAT1-associated interferon-responsive genes’ activation and enhanced chemokine signaling, particularly involving CXCL10 and its receptor CXCR3. These molecular alterations were accompanied by remodeling of intercellular communication among SGCs, sensory neurons, and immune cells. Pharmacological inhibition of STAT1 or blockade of CXCR3 not only reduced sensory-neuron hyperexcitability but also attenuated pain hypersensitivity and improved deficits in hindlimb weight bearing and gait after SNI. Conclusions: Collectively, our findings indicate that interferon-responsive SGCs (IFN SGCs) contribute to the maintenance of neuropathic pain by regulating STAT1-dependent chemokine signaling in the DRG. Targeting this signaling pathway may provide a therapeutic strategy for persistent neuropathic pain.
- Open Access
- 5 February 2025
- Published by Springer Nature in Cell Death Discovery
- Vol. 11 (1) , 1-16
High-altitude hypoxia aggravated neurological deficits in mice induced by traumatic brain injury via BACH1 mediating astrocytic ferroptosis
Traumatic brain injury (TBI) is one of the leading causes of disability and mortality, which was classified as low-altitude TBI and high-altitude TBI. A large amount of literature shows that high-altitude TBI is associated with more severe neurological impairments and higher mortality rates compared to low-altitude TBI, due to the special environment of high-altitude hypoxia. However, the role of high-altitude hypoxia in the pathogenesis of TBI remains unclear. In order to deeply investigate this scientific issue, we constructed a high-altitude hypoxic TBI model at different altitudes and used animal behavioral assessments (Modified neurological severity score, rotarod test, elevated plus maze test) as well as histopathological analyses (brain gross specimens, brain water content, Evans blue content, hypoxia inducible factor-1α, Hematoxylin-Eosin staining and ROS detection) to reveal its underlying principles and characteristics. We found that with higher altitude, TBI-induced neurological deficits were more severe and the associated histopathological changes were more significant. Single-nuclear RNA sequencing was subsequently employed to further reveal differential gene expression profiles in high-altitude TBI. We found a significant increase in ferroptosis of astrocytes in cases of high-altitude TBI compared to those at low-altitude TBI. Analyzing transcription factors in depth, we found that Bach1 plays a crucial role in regulating key molecules that induce ferroptosis in astrocytes following high-altitude TBI. Down-regulation of Bach1 can effectively alleviate high-altitude TBI-induced neurological deficits and histopathological changes in mice. In conclusion, high-altitude hypoxia may significantly enhance the ferroptosis of astrocytes and aggravate TBI by up-regulating Bach1 expression. Our study provides a theoretical foundation for further understanding of the mechanism of high-altitude hypoxic TBI and targeted intervention therapy.
- 5 February 2025
- Published by Springer Nature in Cell Death Discovery
- Vol. 11 (1) , 1-16
Open AccessHigh-altitude hypoxia aggravated neurological deficits in mice induced by traumatic brain injury via BACH1 mediating astrocytic ferroptosis
Traumatic brain injury (TBI) is one of the leading causes of disability and mortality, which was classified as low-altitude TBI and high-altitude TBI. A large amount of literature shows that high-altitude TBI is associated with more severe neurological impairments and higher mortality rates compared to low-altitude TBI, due to the special environment of high-altitude hypoxia. However, the role of high-altitude hypoxia in the pathogenesis of TBI remains unclear. In order to deeply investigate this scientific issue, we constructed a high-altitude hypoxic TBI model at different altitudes and used animal behavioral assessments (Modified neurological severity score, rotarod test, elevated plus maze test) as well as histopathological analyses (brain gross specimens, brain water content, Evans blue content, hypoxia inducible factor-1α, Hematoxylin-Eosin staining and ROS detection) to reveal its underlying principles and characteristics. We found that with higher altitude, TBI-induced neurological deficits were more severe and the associated histopathological changes were more significant. Single-nuclear RNA sequencing was subsequently employed to further reveal differential gene expression profiles in high-altitude TBI. We found a significant increase in ferroptosis of astrocytes in cases of high-altitude TBI compared to those at low-altitude TBI. Analyzing transcription factors in depth, we found that Bach1 plays a crucial role in regulating key molecules that induce ferroptosis in astrocytes following high-altitude TBI. Down-regulation of Bach1 can effectively alleviate high-altitude TBI-induced neurological deficits and histopathological changes in mice. In conclusion, high-altitude hypoxia may significantly enhance the ferroptosis of astrocytes and aggravate TBI by up-regulating Bach1 expression. Our study provides a theoretical foundation for further understanding of the mechanism of high-altitude hypoxic TBI and targeted intervention therapy.
- Open Access
- 13 November 2024
- Published by Elsevier in Ageing Research Reviews
- Vol. 102, 102579
Progress in the mechanisms of pain associated with neurodegenerative diseases
- 13 November 2024
- Published by Elsevier in Ageing Research Reviews
- Vol. 102, 102579
Open AccessProgress in the mechanisms of pain associated with neurodegenerative diseases
- Open Access
- 30 October 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (11) , 1598
Identification of a Fibroblast-Related Prognostic Model in Glioma Based on Bioinformatics Methods
Background: Glioma is the most common primary tumor of the central nervous system with a high lethality rate. This study aims to mine fibroblast-related genes with prognostic value and construct a corresponding prognostic model. Methods: A glioma-related TCGA (The Cancer Genome Atlas) cohort and a CGGA (Chinese Glioma Genome Atlas) cohort were incorporated into this study. Variance expression profiling was executed via the “limma” R package. The “clusterProfiler” R package was applied to perform a GO (Gene Ontology) analysis. The Kaplan–Meier (K–M) curve, LASSO regression analysis, and Cox analyses were implemented to determine the prognostic genes. A fibroblast-related risk model was created and affirmed by independent cohorts. We derived enriched pathways between the fibroblast-related high- and low-risk subgroups using gene set variation analysis (GSEA). The immune infiltration cell and the stromal cell were calculated using the microenvironment cell populations-counter (MCP-counter) method, and the immunotherapy response was assessed with the SubMap algorithm. The chemotherapy sensitivity was estimated using the “pRRophetic” R package. Results: A total of 93 differentially expressed fibroblast-related genes (DEFRGs) were uncovered in glioma. Seven prognostic genes were filtered out to create a fibroblast-related gene signature in the TCGA-glioma cohort training set. We then affirmed the fibroblast-related risk model via TCGA-glioma cohort and CGGA-glioma cohort testing sets. The Cox regression analysis proved that the fibroblast-related risk score was an independent prognostic predictor in prediction of the overall survival of glioma patients. The fibroblast-related gene signature revealed by the GSEA was applicable to the immune-relevant pathways. The MCP-counter algorithm results pointed to significant distinctions in the tumor microenvironment between fibroblast-related high- and low-risk subgroups. The SubMap analysis proved that the fibroblast-related risk score could predict the clinical sensitivity of immunotherapy. The chemotherapy sensitivity analysis indicated that low-risk patients were more sensitive to multiple chemotherapeutic drugs. Conclusion: Our study identified prognostic fibroblast-related genes and generated a novel risk signature that could evaluate the prognosis of glioma and offer a theoretical basis for clinical glioma therapy.
- 30 October 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (11) , 1598
Open AccessIdentification of a Fibroblast-Related Prognostic Model in Glioma Based on Bioinformatics Methods
Background: Glioma is the most common primary tumor of the central nervous system with a high lethality rate. This study aims to mine fibroblast-related genes with prognostic value and construct a corresponding prognostic model. Methods: A glioma-related TCGA (The Cancer Genome Atlas) cohort and a CGGA (Chinese Glioma Genome Atlas) cohort were incorporated into this study. Variance expression profiling was executed via the “limma” R package. The “clusterProfiler” R package was applied to perform a GO (Gene Ontology) analysis. The Kaplan–Meier (K–M) curve, LASSO regression analysis, and Cox analyses were implemented to determine the prognostic genes. A fibroblast-related risk model was created and affirmed by independent cohorts. We derived enriched pathways between the fibroblast-related high- and low-risk subgroups using gene set variation analysis (GSEA). The immune infiltration cell and the stromal cell were calculated using the microenvironment cell populations-counter (MCP-counter) method, and the immunotherapy response was assessed with the SubMap algorithm. The chemotherapy sensitivity was estimated using the “pRRophetic” R package. Results: A total of 93 differentially expressed fibroblast-related genes (DEFRGs) were uncovered in glioma. Seven prognostic genes were filtered out to create a fibroblast-related gene signature in the TCGA-glioma cohort training set. We then affirmed the fibroblast-related risk model via TCGA-glioma cohort and CGGA-glioma cohort testing sets. The Cox regression analysis proved that the fibroblast-related risk score was an independent prognostic predictor in prediction of the overall survival of glioma patients. The fibroblast-related gene signature revealed by the GSEA was applicable to the immune-relevant pathways. The MCP-counter algorithm results pointed to significant distinctions in the tumor microenvironment between fibroblast-related high- and low-risk subgroups. The SubMap analysis proved that the fibroblast-related risk score could predict the clinical sensitivity of immunotherapy. The chemotherapy sensitivity analysis indicated that low-risk patients were more sensitive to multiple chemotherapeutic drugs. Conclusion: Our study identified prognostic fibroblast-related genes and generated a novel risk signature that could evaluate the prognosis of glioma and offer a theoretical basis for clinical glioma therapy.